Welcome to our dedicated page for Inverse VIX S/T Futs ETNs due Mar22,2045 SEC filings (Ticker: VYLD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Inverse VIX S/T Futs ETNs due Mar22,2045's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Inverse VIX S/T Futs ETNs due Mar22,2045's regulatory disclosures and financial reporting.
JPMorgan Chase Financial Company LLC priced a small ($943,000) issuance of Uncapped Buffered Return Enhanced Notes linked to the EURO STOXX 50 Index on 10-Jul-2025. The $1,000-denomination notes settle 15-Jul-2025 and mature 16-Jul-2027.
Payoff profile: investors receive 1.2405× any positive index performance at maturity with no upside cap. A 15 % buffer protects principal for moderate declines; below that threshold principal erodes point-for-point, exposing holders to as much as an 85 % loss. No interest or dividends are paid during the two-year term.
Economics: price to public includes a $17.50 (1.75 %) selling commission. The estimated fair value is $976 per note (2.4 % below issue price) due to embedded distribution and hedging costs. CUSIP 48136E7A7.
Credit & liquidity: the notes are unsecured, unsubordinated obligations of JPMorgan Financial and are fully guaranteed by JPMorgan Chase & Co.; repayment depends on the creditworthiness of both entities. No exchange listing is planned, so resale liquidity relies on dealer bids, likely at a discount.
Risk highlights: potential loss of up to 85 % of principal, no periodic income, model-price/market-price divergence, early acceleration on change-in-law, and exposure to index constituents’ country and market risks. Although relevant to structured-product buyers, the deal size is immaterial to JPM’s consolidated financials.